274 related articles for article (PubMed ID: 8687446)
1. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
Heller RS; Kieffer TJ; Habener JF
Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
[TBL] [Abstract][Full Text] [Related]
2. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
Dillon JS; Lu M; Bowen S; Homan LL
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
Widmann C; Bürki E; Dolci W; Thorens B
Mol Pharmacol; 1994 May; 45(5):1029-35. PubMed ID: 8190093
[TBL] [Abstract][Full Text] [Related]
4. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
5. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
Van Eyll B; Göke B; Wilmen A; Göke R
Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
[TBL] [Abstract][Full Text] [Related]
6. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional expression of a human glucagon-like peptide-1 receptor.
Graziano MP; Hey PJ; Borkowski D; Chicchi GG; Strader CD
Biochem Biophys Res Commun; 1993 Oct; 196(1):141-6. PubMed ID: 8216285
[TBL] [Abstract][Full Text] [Related]
8. The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.
Dillon JS; Wheeler MB; Leng XH; Ligon BB; Boyd AE
Adv Exp Med Biol; 1997; 426():113-9. PubMed ID: 9544263
[No Abstract] [Full Text] [Related]
9. The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.
Takhar S; Gyomorey S; Su RC; Mathi SK; Li X; Wheeler MB
Endocrinology; 1996 May; 137(5):2175-8. PubMed ID: 8612565
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucagon-like peptide-1 receptor and calcium-sensing receptor signaling by L-histidine.
Leech CA; Habener JF
Endocrinology; 2003 Nov; 144(11):4851-8. PubMed ID: 12959987
[TBL] [Abstract][Full Text] [Related]
11. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
12. The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation.
Vázquez P; Roncero I; Blázquez E; Alvarez E
J Endocrinol; 2005 Jul; 186(1):221-31. PubMed ID: 16002551
[TBL] [Abstract][Full Text] [Related]
13. Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.
Doyle ME; Greig NH; Holloway HW; Betkey JA; Bernier M; Egan JM
Endocrinology; 2001 Oct; 142(10):4462-8. PubMed ID: 11564711
[TBL] [Abstract][Full Text] [Related]
14. A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.
Beinborn M; Worrall CI; McBride EW; Kopin AS
Regul Pept; 2005 Aug; 130(1-2):1-6. PubMed ID: 15975668
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
Yang H; Egan JM; Wang Y; Moyes CD; Roth J; Montrose MH; Montrose-Rafizadeh C
Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling.
Fernandez LM; Puett D
Biochemistry; 1996 Apr; 35(13):3986-93. PubMed ID: 8672431
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.
Zhou J; Montrose-Rafizadeh C; Janczewski AM; Pineyro MA; Sollott SJ; Wang Y; Egan JM
J Cell Physiol; 1999 Dec; 181(3):470-8. PubMed ID: 10528233
[TBL] [Abstract][Full Text] [Related]
19. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
Katsuma S; Hirasawa A; Tsujimoto G
Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release.
Gromada J; Rorsman P; Dissing S; Wulff BS
FEBS Lett; 1995 Oct; 373(2):182-6. PubMed ID: 7589461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
